For example, we and others reported somatic mutations in the splicing factor genes RBM10 and U2AF1 in lung adenocarcinoma (LADC), the most prevalent histological subtype of non-small cell lung cancer (NSCLC), with mutation frequencies of approximately 7–8% and 3%, respectively5–7. This evidence concerns the gene RBM10 and non-small cell lung carcinoma.